Close Menu

Duke

In Cell this week: strategy for prophylactic antiviral CRISPR in human cells; influence of obesity, genetics, and hormone signaling on pancreatic ductal adenocarcinoma; and more.

The seven-year grant renews funding for the Antibacterial Resistance Leadership Group, led by Duke University and UCSF, with $15 million in 2020.

Retraction Watch reports that the National Institutes of Health plans to remove conditions it placed on Duke University in 2018 following instances of research misconduct.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

Not a Dime Again

A former Duke University biologist who was found to have fabricated data in 39 papers has been banned from receiving federal funding.

A new sequencing-based method developed by Duke University's Kate Meyer is one of several that can detect RNA methylation without the use of antibodies.

Additional 'Geniuses'

The MacArthur Foundation has revealed this year's recipients of its 'genius' award, the New York Times reports.

The researchers repurposed type I variants of class 1 CRISPR systems to make them usable for DNA targeting and transcriptional control.

Exome sequencing and other molecular strategies led to a heterogeneous variant in the DNMT3A gene that appears to impact host epigenetic and immune features.

In PNAS this week: characterization of an alternatively spliced autism-linked gene, horizontal gene transfer in soil bacteria, and more.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.